Blood Bags Market By Product Type (Single Blood Bag, Double Blood Bag, Triple Blood Bag, Quadruple Blood Bag, Penta Blood Bag, Transfer Bags, Others), By Application (Whole Blood Collection, Blood Component Separation, Leukoreduction, Therapeutic Apheresis, Transfusion), By Material (Polyvinyl Chloride (PVC), Polyolefin, Polyethylene Terephthalate (PET), Polypropylene (PP), Others), By Type of Blood Collection (Manual Blood Collection, Automated Blood Collection), By Volume Capacity (100 ml, 250 ml, 350 ml, 400 ml, 450 ml, 500 ml, Others), and By End User (Hospitals, Blood Banks, Ambulatory Surgical Centers, Diagnostic Laboratories, Academic & Research Institutions, Military Healthcare Facilities), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

---

Industry Outlook

The Blood Bags market accounted for USD 339.76 Million in 2024 and USD 362.59 Million in 2025 is expected to reach USD 694.83 Million by 2035, growing at a CAGR of around 6.72% between 2025 and 2035. The blood bags market can be defined as the market working in the production, distribution, and sale of specialised sterile bags meant to store, collect, and transport blood and blood components. The bags are critical in health institutions, blood banks, and transfusion facilities where there is a need to store blood safely while at the same time ensuring its quality and contamination-free status. Factors contributing to the growth of the market are the rising blood transfusions, the development of technology in blood storage, and the rise in safe blood donation information. It contains a variety of blood bags, including single, double, triple, and quadruple bags, and they aim at separating different blood components (plasma, platelets, red blood cells). The blood bag market is generally useful in the maintenance of healthcare infrastructure across the globe.

Industry Experts Opinion

"The Reveos Automated Whole Blood System significantly reduces manual steps in component processing—from up to 18–20 down to 5–7—helping blood centers increase platelet supply and operational efficiency."

• Dr. Chetan Makam, General Manager of Global Blood Solutions at Terumo Blood and Cell Technologies

Report Scope:

Market Dynamics

Rising trauma cases boosting demand for efficient blood storage systems

An increase in trauma cases globally is one of the key growth factors of the blood bags market because, during emergency medical care, there is a need for an efficient blood-storing and transfusion mechanism. The World Health Organisation (WHO) has estimated that more than 118 million blood donations are obtained annually around the world, which highlights the urgent need for safe and desirable blood storage.

Traumatic wounds on body parts through accidents, violence, and disasters have increased as the main causes of death, leading to more blood products for young adults, a factor reported by the Centers for Disease Control and Prevention (CDC). There are chronic diseases such as cancer and anaemia, which also give lasting demand since the sickly people usually need transfusions.

Massive blood donation campaigns have been initiated by governments and health agencies to keep the stocks up, and a proper unit of blood bag is approximated to be the one that guarantees sterility, shelf life, and compatibility. All these contribute to the innovation and development of blood-storing systems that are inevitable in the current medical industry.

Increasing surgical procedures require stable and safe blood handling

The blood bags market is boosted by the increasing number of surgical operations in various parts of the world, as surgical operations strive to utilise quality and efficient blood storage and transfusions. Trauma cases, chronic diseases, and transplantation of organs have increased, and this has increased the demand for blood collection and storage mechanisms.

According to the World Health Organisation (WHO), around 112.5 million units of blood collected annually all over the world indicate the enormity of managing blood associated with it. Another significant fact is that the United States National Institutes of Health (NIH) indicate that 15 million blood parts are transfused in the United States alone per year. More countries have an ageing population, and this is reason enough to feed the demand through surgery.

The FDA and other regulatory bodies have high safety regulations on blood products, and this ensures that there is improved blood bag technology. Further, an increase in awareness regarding blood donation and the introduction of better methods of blood preservation make blood storage more efficient and safer. All these aspects contribute to the ability to maintain steady growth and innovations in the blood bag industry, and it is one of the indispensable parts of the current healthcare infrastructure.

Limited awareness in rural regions regarding modern blood collection techniques

Strong ignorance concerning contemporary blood collection methods in the rural areas greatly curtails the expansion of the blood bags market. The problem is that many blood donation camps and rural healthcare centres continue using outdated or manual workflows to organise their work, which makes them inefficient and even unsafe.0020The National Health Mission (NHM) reports reveal that more than 65% of the rural population has inadequate access to advanced healthcare facilities, including safe blood transfusion services, in India.

Lack of awareness and infrastructure constrain the usage of specialised blood bags, which increases the storage period without contamination and offers better blood protection. Moreover, research presented by the Indian Council of Medical Research (ICMR) shows that most of the healthcare workers and rural donors are less trained on the advantages and application of newfangled blood collection apparatus, thereby hindering demand. All these render penetration of the market in such areas slow and limit the growth of the general market despite the increased demand in the urban areas.

Technological innovations enhancing durability and traceability of blood bags

Blood bags are going through a lot of changes thanks to new technologies like high-performance polymer material and RFID/NFC tagging. The blood bags market has a lot of room to develop because these changes make the bags more durable and easier to track. These advancements aid in preserving the quality of blood that is being stored and transported by avoiding contamination and enhancing the lifespan of the shelf life. Blood units will be traceable, which means that it will be possible to monitor their movement in real-time, making transfusion practice safer and errors less common.

The U.S. Food and Drug Administration (FDA) argues that enhanced packaging and preservation techniques result in better blood preservation and wastage reduction, which is vital since it experiences more than 13 million blood units collected, despite these 13 million units being collected in the United States alone (American Red Cross).

Various reports given by the World Health Organisation indicate that safe blood transfusion services internationally need assured blood traceability systems, necessitating the development of new forms of blood bags, both in the developed and emerging healthcare markets. This is a golden opportunity for manufacturers to serve hospitals and blood banks aimed at improving patient safety and efficiency of operations.

Expansion in untapped markets with rising healthcare funding and awareness

The blood bags market has great potential in the untapped areas due to the growing healthcare investment and the popularisation of blood safety and donation. The World Health Organisation (WHO) indicates that to meet the needs of about 118.5 million people through a collection of blood donations, experiencing a shortage in many low- and middle-income countries, about 20 per cent of the 55 countries are facing a critical shortage linked to the limited number of low rates of voluntary blood donation.

An example is recorded in India, where the National AIDS Control Organisation (NACO) reported the shortage in blood demand and supply, where an annual 12 million units are required, but less than 9 million units are received. Efforts made by governments to encourage non-paid and voluntary blood donation have enhanced safety and availability, yet a lot still needs to be done, particularly in the rural and distant regions where awareness is not yet high.

Government and non-governmental organisations are raising investments in the healthcare infrastructure and creating awareness, which is increasing the demand for quality blood bags that would facilitate safe collection, storage, and transfusion of the blood components. Learnt places highlight the means of safe blood transfusion conduit, which has its boom impact on the market growth. With improved blood transfusion services and the adoption of digital blood management solutions, the market is set to experience a steep rise in demand for enhanced blood bags bearing such features as improved sterilisation and prolonged shelf life across the emerging economies.

Segment Analysis

Based on the product type, the Blood Bags market has been classified into Single Blood Bag, Double Blood Bag, Triple Blood Bag, Quadruple Blood Bag, Penta Blood Bag, Transfer Bags, and Others. The Blood Bags Market has the Triple Blood Bag segment as the most noticeable one. This is mainly attributed to its wide application in separating blood components, since through it, red blood cells, plasma, and platelets can be collected and stored from one donation. The hospitals and the blood banks use triple bags because they are highly effective and have various applications in transfusion practice. Increasing need for component therapy and the best use of every donation of blood support the market share of this segment. It also helps in better management of inventory and addresses individual clinical needs.

Based on the application, the Blood Bags market has been classified into Whole Blood Collection, Blood Component Separation, Leukoreduction, Therapeutic Apheresis, and Transfusion. The most prevailing application segment when it comes to the Blood Bags Market is Blood Component Separation. In this technique, a single donation can be separated into red cells, plasma, and platelets so that each unit of blood can be utilized more effectively. It helps in enabling patients to be treated specifically, and relationship outcomes in surgery, trauma, and chronic diseases such as anemia and cancer. The trend that shifted towards component therapy as opposed to whole blood transfusion has caused a great demand for special blood bags. This has been contributed by the medical innovations as well as practices within blood banks that have been effective.

Regional Analysis

The United States blood bags market indicates a well-developed and controlled health setting, characterized by excellent medical infrastructure and the occurrence of a prevalent demand for blood transfusions during surgical activities, trauma treatment, and management of long-term illnesses.

The regional distribution of the market has been such that major concentration can be found in the Northeast, Northwest, and West Coast, because of the presence of major hospitals and research centers. The markets in the southern states are picking up, as the number of people who have access to healthcare increases and increased density increases. The market growth has further been fuelled by the technological progress in blood storage and the growing awareness of blood donation.

High-quality products and safety are guaranteed since all products have to meet the strict FDA regulations and standards, allowing creating the competitive environment. The manufacturers adopt the strategy of partnering with both their private and public healthcare institutions, which would help in having a constant supply, especially during emergency preparedness. Inequality in healthcare financing and service facing geography is perhaps a minor factor influencing adoption rates, although overall, the U.S market is strong and innovative.

The Asia Pacific blood bags market trends are showing rather remarkable growth due to the increasing healthcare infrastructure investment and the need for blood transfusion in the corresponding location. High population density of countries such as China, India, Japan, and South Korea is a major contributor to these countries due to increased surgical operations and knowledge on blood donations.

Improvement of the technology behind storing and collecting blood, and government efforts to provide healthcare along with increased access, are further drivers of the market. Further, there is an increase in the incidence of chronic cases and traumas, which are raising the demand for authentic blood supply systems. Nevertheless, differences between regions in terms of healthcare and regulatory systems may also become an issue.

A growing network of blood for and better-structured medical logistics maintains the market growth. Access to quality blood products is also improving because of the emergence of public-private partnerships. Further, this trend is likely to result in greater innovation in blood bag technology in the region due to an increase in investment in healthcare research and development.

Competitive Landscape

The blood bags market is characterised by the intense rivalry of the major international companies, including Terumo Corporation, Fresenius SE & Co. KGaA, Haemonetics Corporation, Grifols, SA, and Macopharma SA. These companies have decided to remain innovative via the incorporation of advanced materials and upgrading the level of sterility to fulfill the changing demands of the regulations. Automation and pathogen-reduction technology have increasingly been the targets of Terumo in the recent past to make blood collection safer.

Haemonetics is advocating smarter blood management and making sure the transfusion systems are digitally integrated with tracking capabilities. On an interim basis, Fresenius and Grifols are investing in Salsa-free and plasma-plasticised systems that look into both environmental and clinical issues. With CE-labelled filtration technologies, Macopharma is growing in Europe. Local companies in India and Africa are making advances by setting up national production and using drone logistics as a means of delivering to rural areas faster. All these developments are an indication of a move towards safer, more regional, and technology-based blood management solutions.

Blood Bags Market, Company Shares Analysis, 2024

To explore in-depth analysis in this report - Request Sample Report

Recent Developments:

• In March 2025, the FDA approved SkinDisc™ Lite, a blood processing device developed by Innoveren Scientific in the USA. The device was designed to prepare platelet-rich and platelet-poor plasma at the point of care. It supported treatments for surgical procedures and chronic wounds. This approval marked a step forward in improving patient care through on-site blood component preparation.
• In February 2024, Xheme Inc. partnered with the Vitalant Research Institute in the USA to develop non-PVC blood bag films. The goal was to create more sustainable alternatives to traditional medical plastics. This collaboration aimed to address stricter EU regulations. The project focused on improving environmental safety in blood storage materials.

Report Coverage:

By Product Type

• Single Blood Bag
• Double Blood Bag
• Triple Blood Bag
• Quadruple Blood Bag
• Penta Blood Bag
• Transfer Bags
• Others

By Application

• Whole Blood Collection
• Blood Component Separation
• Leukoreduction
• Therapeutic Apheresis
• Transfusion

By Material

• Polyvinyl Chloride (PVC)
• Polyolefin
• Polyethylene Terephthalate (PET)
• Polypropylene (PP)
• Others

By Type of Blood Collection

• Manual Blood Collection
• Automated Blood Collection

By Volume Capacity

• 100 ml
• 250 ml
• 350 ml
• 400 ml
• 450 ml
• 500 ml
• Others

By End User

• Hospitals
• Blood Banks
• Ambulatory Surgical Centers
• Diagnostic Laboratories
• Academic & Research Institutions
• Military Healthcare Facilities

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of the Middle East & Africa

List of Companies:

• Terumo Corporation
• Fresenius SE & Co. KGaA
• Grifols, S.A.
• Haemonetics Corporation
• Macopharma SA
• INNVOL Medical India Limited
• HLL Lifecare Limited
• Neomedic Limited
• Poly Medicure Limited
• Span Healthcare Private Limited
• JMS Co., Ltd.
• Teleflex Incorporated
• B. Braun Melsungen AG
• Kawasumi Laboratories Inc.
• Mitra Industries Pvt. Ltd.

Frequently Asked Questions (FAQs)